Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment Resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT01372722
What this trial is testing

Deep Brain Stimulation (DBS) for Treatment Resistant Bipolar Disorder

Who this might be right for
Bipolar Disorder
University Hospital, Bonn
Post-approval studies (Phase 4)UnknownNCT02562287
What this trial is testing

Clozapine Versus Other Atypical Antipsychotics for Bipolar Disorder

Who this might be right for
Bipolar Disorder
Hospital de Clinicas de Porto Alegre 54
Not applicableStudy completedNCT06408051
What this trial is testing

Efficacy of 200 IU OnabotulinumtoxinA in Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment

Who this might be right for
Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment
Hisar Intercontinental Hospital 60
Not applicableNot Yet RecruitingNCT06520800
What this trial is testing

Treatment and Handling Severe Obesity-Related Comorbidities in Adolescents Through Exercise

Who this might be right for
Adolescent ObesityHypertension,EssentialNon-Alcoholic Fatty Liver Disease+3 more
University of Lisbon 24
Not applicableUnknownNCT05567237
What this trial is testing

Effects of Microcurrent Treatment With and Without Resistance Exercises

Who this might be right for
SarcopeniaAgeing Well
University of Greenwich 40
Large-scale testing (Phase 3)UnknownNCT04335032
What this trial is testing

EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2)

Who this might be right for
SARS-CoV-2
S.L.A. Pharma AG 284
Testing effectiveness (Phase 2)UnknownNCT04963595
What this trial is testing

Pyrotinib and Vinorelbine Tartrate Capsules With or Without Inetetamab for First Line Treatment in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Zhiyong Yu 100
Testing effectiveness (Phase 2)UnknownNCT06509971
What this trial is testing

QL1706 (an Anti-PD-1/CTLA-4 Combined Antibody) Combined With Albumin-bound Paclitaxel and Bevacizumab in the Treatment of Platinum-resistant Recurrent Ovarian Cancer

Who this might be right for
Platinum-resistant Recurrent Ovarian Cancer
West China Second University Hospital 39
Not applicableUnknownNCT05493319
What this trial is testing

Hypopressive Exercise Associated With Strength and Resistance Training in Women Treated for Gynecological Cancer

Who this might be right for
Gynecologic Cancer
Universidade Federal de Sao Carlos 36
Not applicableUnknownNCT03741192
What this trial is testing

Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patient's Refractory to AEDs

Who this might be right for
Epilepsy Intractable
Brain Sentinel 58
Large-scale testing (Phase 3)Study completedNCT00002245
What this trial is testing

The Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients

Who this might be right for
HIV Infections
Glaxo Wellcome
Post-approval studies (Phase 4)Study completedNCT00356395
What this trial is testing

Safety and Effects of Ramipril Combined With Candesartan

Who this might be right for
Hypertension
Gachon University Gil Medical Center 40
Not applicableActive Not RecruitingNCT04150939
What this trial is testing

Cryoablation for the Treatment of Metastatic Cancer

Who this might be right for
Metastatic Malignant Neoplasm
M.D. Anderson Cancer Center 15
Not applicableStudy completedNCT06307457
What this trial is testing

HR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inhibitor From 2017 to 2023 in Denmark.

Who this might be right for
Breast Cancer
Pfizer 604
Not applicableUnknownNCT03314012
What this trial is testing

First-In-Human Study Evaluating a Novel Catheter Device in Subjects With Treatment-Resistant Hypertension

Who this might be right for
Hypertension,Essential
Cibiem, Inc. 39
Early research (Phase 1)Study completedNCT00868595
What this trial is testing

MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer

Who this might be right for
Castrate Resistant Prostate Cancer (CRPC)
Bellicum Pharmaceuticals 18
Testing effectiveness (Phase 2)WithdrawnNCT05652465
What this trial is testing

Transcranial Magnetic Stimulation for Youth With Treatment-Resistant Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
National Institute of Mental Health (NIMH)
Testing effectiveness (Phase 2)Active Not RecruitingNCT03944772
What this trial is testing

Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 247
Post-approval studies (Phase 4)UnknownNCT01201239
What this trial is testing

Efficacy and Safety of Raltegravir (RAL) in Treatment-experienced HIV-1 Infected Adult Chinese Patients

Who this might be right for
HIV
Shanghai Public Health Clinical Center 50
Large-scale testing (Phase 3)Active Not RecruitingNCT06303739
What this trial is testing

Psilocybin-Assisted Therapy in Treatment-Resistant Depression

Who this might be right for
Refractory DepressionTreatment Resistant Depression
University of North Carolina, Chapel Hill 20
Next Page